← Open Payments lookup

DEVAN COOPER MCALL: Open Payments

NPI 1598461527 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$909 in 79 payments from 12 companies in 2025. Trend: 2023 $800 · 2024 $1,564 · 2025 $909

Food & beverage: $909
CompanyPaymentsAmount
Amgen Inc.31$212
Novo Nordisk Inc17$178
Sumitomo Pharma America, Inc.9$143
Boehringer Ingelheim Pharmaceuticals, Inc.4$69
Lilly USA, LLC4$67
Bayer Healthcare Pharmaceuticals Inc.3$56
AstraZeneca Pharmaceuticals LP3$54
ABBVIE INC.3$51
GlaxoSmithKline, LLC.2$32
Esperion Therapeutics, Inc.1$18

Products named: OTEZLA, GEMTESA, Wegovy, Kerendia, Ozempic, Rybelsus, REPATHA, AIRSUPRA.

Industry payments across AL — which companies pay providers there.